AF
AFIB.US Acutus Medical Inc
- Market cap
- USD 2.99K
- P/E
- -
- P/B
- 0.16x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2024.
Is AFIB.US undervalued?
Graham numberThe Graham number of Acutus Medical Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Acutus Medical Inc fundamental analysis
No fundamental analysis for Acutus Medical Inc yet.
Acutus Medical Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Acutus Medical Inc
Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorpor…
Full company profileAcutus Medical Inc financial statements
Acutus Medical Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 2.17M | 2.84M | 8.46M | 17.3M | 3.03M | 7.16M | 20.2M |
| Gross Profit | -5.34M | -6.41M | -7.43M | -15.7M | -1.91M | -3.14M | 1.01M |
| Operating Income | -37.8M | -72.6M | -91.3M | -116M | -23.0M | -14.4M | -57.0K |
| EBITDA | -40.6M | -71.6M | -92.5M | -105M | 35.2M | -5.33M | 2.25M |
| Net Income | -47.9M | -97.0M | -102M | -118M | -39.6M | -81.7M | -9.55M |
| EPS | -2.84 | -3.54 | -8.94 | -4.11 | -1.39 | -2.81 | -0.32 |
| Balance Sheet | |||||||
| Total Assets | 25.9M | 105M | 193M | 170M | 133M | 54.0M | 28.6M |
| Total Liabilities | 158M | 331M | 66.0M | 64.1M | 58.4M | 54.8M | 40.2M |
| Shareholders' Equity | -132M | -226M | 127M | 106M | 75.0M | -879K | -11.6M |
| Cash & Short-term Investments | 17.7M | 71.8M | 131M | 101M | 70.4M | 22.4M | 14.0M |
| Total Debt | 25.9M | 41.1M | 41.1M | 45.4M | 38.9M | 38.5M | 35.8M |
| Cash Flow | |||||||
| Operating Cash Flow | -33.8M | -56.0M | -85.2M | -99.7M | -85.0M | -63.1M | -31.7M |
| Capital Expenditure | 2.04M | 13.4M | 11.2M | 9.97M | 3.98M | 219K | 112K |
| Free Cash Flow | -35.8M | -69.4M | -96.4M | -110M | -89.0M | -63.3M | -31.8M |
| Ratios | |||||||
| ROE | - | - | -80.6% | -111.3% | -52.8% | - | - |
| ROA | -184.6% | -92.0% | -53.0% | -69.3% | -29.7% | -151.3% | -33.3% |
| Net Profit Margin | -2,211.8% | -3,421.7% | -1,204.9% | -681.7% | -1,307.0% | -1,139.9% | -47.4% |
| Debt to Equity | - | - | 0.32x | 0.43x | 0.52x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Acutus Medical Inc dividends
Acutus Medical Inc has not paid dividends in the last 7 fiscal years.
Who owns Acutus Medical Inc
- Insiders 1.35%
- Institutions 8.85%
- Public & others 89.80%
- Shares outstanding 29.9M
- Free float 29.9M
Top funds holding AFIB.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Guggenheim Active Allocation Fund | 113.00 | 0.00% | 0.00% | Nov 2024 |
Top institutions holding AFIB.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| S.A. Mason LLC | 3.00K | 0.01% | 0.00% | Dec 2024 |
| Northern Trust Investments N A | 0.00 | 0.00% | -100.00% | Dec 2024 |
Acutus Medical Inc company profile
- Company name
- Acutus Medical Inc
- Ticker
- AFIB.US
- Exchange
- USA Stocks
- Listed since
- Aug 6, 2020
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 85
- Fiscal year end
- December
- Address
- 2210 Faraday Avenue, Carlsbad, CA, United States, 92008
- Phone
- 442 232 6080
- Website
- acutusmedical.com
About Acutus Medical Inc
Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.
Acutus Medical Inc management
1- Mr. Takeo MukaiCEO & CFO · born 1980